Evofem Biosciences Inc (EVFM)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

12400 HIGH BLUFF DRIVE SAN DIEGO, CA 92130

Neothetics, Inc. operates as a pharmaceutical company. The Company develops therapeutics addressing lifestyle and medical indications in aesthetic medicine and ophthalmology. Neothetics serves customers in the United States.

Data as of 2020-11-22
Market Cap189.383 Million Shares Outstanding81.28 Million Avg 30-day Volume1.713 Million
P/E Ratio Dividend Yield EPS-1.83
Price/Sales681.234 Price cash flow ratio Price free cash flow ratio-2.5
Book Value0.02 Price to Tangible Book153.09 Alpha0.02
Short Interest Ratio % Short Interest to Float R-squared0.001552
BETA0.361319 52-week High/Low7.5 / 1.91 Stddev0.38647
View SEC Filings from EVFM instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 100 122 -18.03% 27 (1.78%) 36 (2.34%) -25.0%
13F shares: 36.633 Million 42.019 Million -12.82% 4.259 Million 8.862 Million -51.95%
% Ownership 45.07 51.6959 -12.82% 5.2394 10.9036 -51.95%
New Positions: 15 76 -80.26% 3 26 -88.46%
Increased Positions 37 37 0.0% 8 8 0.0%
Closed Positions 35 5 600.0% 12 1 1100.0%
Reduced Positions 25 5 400.0% 14 1 1300.0%
Total Calls 501.359 Thousand 461.117 Thousand 8.73% 41.7 Thousand 110.6 Thousand -62.3%
Total Puts 525.546 Thousand 289.547 Thousand 81.51% 134.5 Thousand 98.5 Thousand 36.55%
PUT/CALL Ratio 1.05 0.63 66.67% 3.23 0.89 262.92%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding EVFM (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EVFM BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

7.8 Thousand total shares from 1 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

FILE JUSTIN J. CHIEF FINANCIAL OFFICER

  • Officer
258,168 2020-11-17 8

BARRANS RUSSELL CHIEF COMMERCIAL OFFICER

  • Officer
279,331 2020-09-10 8

PELLETIER SAUNDRA L CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
360,888 2020-09-08 7

RARICK LISA DALE

  • Director
5,250 2020-06-17 4

HALL WILLIAM WALMSLEY

  • Director
5,000 2020-06-15 3

KAMDAR KIM P.

  • Director
  • 10% Owner
9,287 2020-06-12 2

CULWELL KELLY CHIEF MEDICAL OFFICER

  • Officer
115,451 2020-06-05 6

FITZPATRICK ALEXANDER A GENERAL COUNSEL AND SECRETARY

  • Officer
134,452 2020-06-05 4

LINK FUND SOLUTIONS LTD

  • 10% Owner
0 2020-06-04 1

ACACIA RESEARCH CORP

  • 10% Owner
9,139,504 2020-06-04 2

PDL BIOPHARMA, INC.

  • 10% Owner
0 2020-05-21 1

INVESCO LTD.

  • 10% Owner
13,226,532 2020-05-14 1

GREER GILLIAN

  • Director
0 2020-05-12 1

O'BRIEN ANTHONY STEPHEN

  • Director
0 2020-05-12 1

RUTHERFORD COLIN

  • Director
0 2020-05-12 1

LYNCH THOMAS G

  • Director
325,000 2020-03-31 2

MONNET DOMINIQUE

  • Director
0 2019-06-10 0

KNUDSON SUSAN A. CHIEF FINANCIAL OFFICER

  • Officer
0 2017-06-22 0

FELDMAN MARIA VP, CLINICAL RESEARCH

  • Officer
0 2017-06-22 0

DEMSKI MARTHA J

  • Director
0 2017-06-20 0

GORBACHEV MAXIM

  • Director
0 2017-06-20 0

NUGENT JEFFREY M

  • Director
0 2017-06-20 0

LOCKE KENNETH W CHIEF SCIENTIFIC OFFICER

  • Officer
0 2016-02-04 0

ALTA PARTNERS VIII, L.P.

ALTA PARTNERS MANAGEMENT VIII, LLC

CHAMPSI FARAH

JANNEY DANIEL

NOHRA GUY P

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2015-12-28 0

MAHAFFEY GEORGE W PRESIDENT AND CEO

  • Officer
  • Director
171,040 2015-10-15 0

ZEINI HANI M

  • Director
0 2015-09-23 0

KEMMERER CHRISTOPHER VP, PHARMA DEV & MANUFACTURING

  • Officer
10,848 2015-09-18 0

JANNEY DANIEL

  • Director
  • 10% Owner
0 2015-06-16 0

KROCHMAL LINCOLN CHIEF MEDICAL OFFICER

  • Officer
0 2015-02-10 0

SHAH NIMESH

  • 10% Owner
3,934 2015-01-01 0

RMI INVESTMENTS S.A.R.L.

RUSNANOMEDINVEST LLC

  • 10% Owner
1,585,549 2014-11-25 0

DOMAIN PARTERS VII L P

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

SCHOEMAKER KATHLEEN K

VITULLO NICOLE

HALAK BRIAN K

  • 10% Owner
3,091,643 2014-11-25 0

DP VII ASSOCIATES LP

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

SCHOEMAKER KATHLEEN K

VITULLO NICOLE

HALAK BRIAN K

  • 10% Owner
48,023 2014-11-25 0

WALKER PATRICIA S

  • Director
0 2014-11-19 0

DOMAIN ASSOCIATES

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

SCHOEMAKER KATHLEEN K

VITULLO NICOLE

HALAK BRIAN K

KAMDAR KIM P.

  • Director
  • 10% Owner
3,934 2014-11-19 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

FILE JUSTIN J. - Officer CHIEF FINANCIAL OFFICER

2020-11-18 17:22:52 -0500 2020-11-17 P 7,760 $2.17 a 258,168 direct 0.0 -1.7168 3.0044 3 -3.0044 5

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments